EBF1 and central nervous system cancer: HIF1α in TNBC and NR2F2 in PCa enhance EBF1 expression [27,39], while ZNF521 in GC and Sox2 in glioma act as negative regulators [29,46], indicating that EBF1 functions as a central node at the convergence of multiple signaling pathways.